| Document |
Document Title |
|
WO/2002/044398A2 |
Universal supports for oligonucleotide synthesis include a support material represented by the formula (I). In this formula, substituent A is selected from H, alkyl, aryl, or a polymeric or silica base material; substituent B is selected...
|
|
WO2001042179A9 |
Compounds which mimic the chemical and/or biological activity of discodermolide are provided and intermediates useful in their preparation.
|
|
WO/2002/024613A2 |
The present invention relates to certain resorcinol derivatives and their use as skin lightening agents.
|
|
WO/2002/017712A2 |
Compounds of formula (I): wherein A, B, D, and R are as defined herein and their agriculturally acceptable salts are disclosed as effective insecticides. In addition, compositions comprising an insecticidally effective amount of a compou...
|
|
WO/2002/012149A2 |
The invention concerns a method for preparing alkoxyamines in a biphasic medium. Said method consists in mixing an ionic liquid, an organic solvent, a metal salt, a metal ligand, a halogeno-carbonaceous ZX compound and a nitroxide, maint...
|
|
WO/2002/010226A1 |
The invention relates to an initiator system for radical polymerizations, which is characterized in that a combination of compounds of general formulas (I) and (II) is used, wherein: R?'¿, R?''¿, R?'''¿ and R?''''¿, are selected inde...
|
|
WO/2002/002520A2 |
The present invention is disubstituted amines of formula (I) and disubstituted amines of formula (II) useful in treating Alzheimer's disease and other similar diseases.
|
|
WO/2002/002506A2 |
The present invention is substituted amines of formula (XV) useful in treating Alzheimer's disease and other similar diseases.
|
|
WO/2002/002518A2 |
The present invention is disubstituted amines of formula (I) and disbustituted amines of formula (II) useful in treating Alzheimer's disease and other similar diseases.
|
|
WO/2002/002512A2 |
The present invention is substituted amines of formula (X) useful in treating Alzheimer's disease and other similar diseases.
|
|
WO/2002/002505A2 |
The present invention is substituted amines of formula (X) useful in treating Alzheimer's disease and other similar diseases.
|
|
WO/2001/092218A2 |
Novel 'bispolyamine' inhibitor compounds of polyamine transport are disclosed. These compounds are useful pharmaceutical agents for treating diseases where it is desired to inhibit polyamine transport or other polyamine binding proteins,...
|
|
WO/2001/090113A1 |
The invention relates to novel cyclic and open-chain hydroxylamine esters and polymerizable compositions comprising these hydroxylamine esters and an ethylenically unsaturated monomer or oligomer. The invention also relates to use as pol...
|
|
WO/2001/087822A1 |
The invention relates to phenyl-propargylether derivatives of general formula (I) including the optical isomers thereof and mixtures of such isomers, wherein R¿1? is hydrogen, alkyl, cycloalkyl or optionally substituted aryl, R¿2? and ...
|
|
WO/2001/083455A1 |
Sterically hindered N-substituted aryloxyamines are prepared by the transition-metal-catalyzed decomposition of diazonium salts in the presence of a sterically hindered nitroxyl radical. These compounds are useful as thermal and light st...
|
|
WO/2001/074757A1 |
The instant invention provides a process for the selective N-formylation of N-hydroxylamines.
|
|
WO/2001/060785A1 |
Compounds of formula (I): R¿1?CH¿2?(OR¿2?)ONH¿2?, wherein R¿1? is hydrogen or methyl and R¿2? is a C¿1?-C¿6? alkyl group, or a salt thereof are useful as reagents for the synthesis of biologically active hydroxyaminocarbonyl- and...
|
|
WO/2001/046124A1 |
Aromatic diamide derivatives of general formula (I) or salts thereof; chemicals for agricultural or horticultural use; and usage thereof [wherein A?1¿ is optionally substituted C¿1-8? alkylene, C¿3-8? alkenylene, or the like; B is O- ...
|
|
WO/2001/044154A1 |
Dihalopropenyloxybenzene derivatives represented general formula (I) which have a very excellent effect of controlling pests in the field of agriculture, horticulture, daily life, livestock, pets, etc. (in particular, injurious insects a...
|
|
WO/2001/023435A1 |
Improved polymerization agents and processes are disclosed. In particular, the nitrogen-containing free radicals and free radical precursors are used to effect efficient, controlled polymerization of polymeric materials, including monome...
|
|
WO/2001/007020A2 |
The invention relates to the use of carboxylic acid amides of general formula (I) for inhibiting telomerase, wherein A, B and R¿1? to R¿5? are defined as per claim (1). The invention also relates to novel carboxylic acid amides of gene...
|
|
WO/2001/002345A2 |
The invention pertains to a compound of formula (I), (II) or (III) wherein R¿1? and R¿2? are independently of each other hydrogen, C¿1?-C¿18?alkyl, C¿3?-C¿18?alkenyl, C¿3?-C¿18?alkinyl or phenyl which are unsubstituted or substit...
|
|
WO/2000/078709A1 |
A vinylated alkoxyamine represented by general formula (1) is produced by a process comprising the step of heating divinylbenzene together with a nitroxide compound and an organic peroxide to the heat decomposition temperature of the org...
|
|
WO/2000/078710A1 |
A method for producing hydroxylamine salts by using oximes as a principal reagent and which proceeds through the hydrolyzation of an oxime ether.
|
|
WO/2000/071500A1 |
The invention relates to novel halogen compounds, to a method for producing them and to their use for treating plants for protecting them against attack from phytopathogenic microorganisms and insects. The invention also relates to novel...
|
|
WO/2000/071501A1 |
The invention relates to polyalcoxyamines obtained from $g(b)-substituted nitroxides of formula (1) wherein A represents a di-or polyvalent structure, R¿L? represents a mole weight of more than 15 and is a monovalent radical, and n $m(G...
|
|
WO/2000/056702A1 |
The present invention relates to the use of certain resorcinol derivatives as skin lightening agents.
|
|
WO/2000/055121A1 |
The invention relates to a method for the continuous production of methoxyamine hydrochloride by dissociating acetone oxime dimethyl ether with hydrogen chloride and water. The inventive method is characterized by carrying out the dissoc...
|
|
WO/2000/050621A2 |
A process for producing aldehydes, and/or carboxylic acids is described, in which a primary alcohol, especially a carbohydrate, is oxidised using a catalytic amount of a nitrosonium compound obtained by oxidising a nitroxyl compound in t...
|
|
WO/2000/050388A1 |
A process for producing nitrosonium ions is described, in which a nitroxyl compound such as TEMPO is oxidised using an oxidising agent in the presence of a complex of a transition metal such as Mn, Fe, Cu, and a complexing agent such as ...
|
|
WO/2000/048988A1 |
Compounds of formula (1) and the pharmaceutically acceptable salts and esters thereof wherein X and Y are as defined in the specification, are effective inhibitors of the binding of VCAM-1 to VLA-4 $i(in vivo) and are useful in treating ...
|
|
WO2000006533B1 |
A compound of formula (I) where R<1> is CH and R<6> is a bond, or R<1> and R<6> together form an electron withdrawing group; R<2> and R<3> are independently selected from (CR<7>R<8>)n, or a group CR<9>R<10>, -(CR<7>R<8>CR<9>R<10>)- or -(...
|
|
WO/2000/027780A1 |
Methods and compositions for inhibiting the polymerization of ethylenically unsaturated hydrocarbons are disclosed. Combinations of aminophenol compound and either of phenylenediamine or hydroxylamine compounds are effective at inhibitin...
|
|
WO/2000/018724A1 |
The invention relates to substituted aryl and heteroaryl (R)-Chiral Halogenated 1-Substitutedamino-(n+1)-Alkanol compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, ...
|
|
WO/2000/018721A1 |
The invention relates to substituted polycyclic aryl and heteroaryl $i(tertiary)-heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions an...
|
|
WO/2000/011039A2 |
An aqueous phase inhibitor for quenching free radical polymerization comprising a free radical quenching agent having a hydrophilic tail is disclosed, as well as a coating and related methods. In one embodiment, the free radical quenchin...
|
|
WO/2000/007981A1 |
The invention relates to a compound of formula (Ia), (Ib) or (Ic). The open chain alkoxyamine compounds are useful for the polymerization of ethylenically unsaturated monomers. The compounds of the present invention provide polymeric res...
|
|
WO/2000/006137A2 |
Compounds having Formula (I) are useful for modulating the glucocorticoid receptor in a mammal. Also disclosed are pharmaceutical compositions comprising compounds of Formula (I) and methods of treating immune, autoimmune, inflammatory, ...
|
|
WO/2000/004865A2 |
Synthetic methods for lactone-containing compounds such as the discodermolides are provided, as are compounds which mimic the chemical and/or biological activity thereof, and methods and intermediates useful in their preparation.
|
|
WO/2000/002848A1 |
Novel salts of $i(N-tert)-butylhydroxylamine with lower carboxylic acids are disclosed, together with processes for their preparation. The salts possess advantageous properties that render them useful in synthesis.
|
|
WO/1999/067192A2 |
This invention is directed to a process for the solid phase synthesis of aldehyde, ketone, oxime, amine, hydroxamic acid and $g(a),$g(b)-unsaturated carboxylic acid and aldehyde compounds and to polymeric hydroxylamine resin compounds us...
|
|
WO/1999/036393A1 |
The present invention relates to a pharmaceutical composition comprising as an active ingredient a compound of formula (I), wherein Ring A is an aromatic or a heterocyclic ring; Q is a bond, carbonyl, lower alkylene, lower alkenylene, -O...
|
|
WO/1999/031074A2 |
Novel amines of formulas (1A) and (1B) or a pharmaceutically acceptable salt thereof wherein: n is an integer of from 0 to 2; R is sulfonamide, amide, phosphonic acid, heterocycle, sulfonic acid, or hydroxamic acid; A is hydrogen or meth...
|
|
WO/1999/031075A1 |
Novel amines of formulas (1), (1C), (1F), (1G) and (1H) or a pharmaceutical acceptable salt thereof wherein n is an integer of from 0 to 2; m is an integer of from 0 to 3; R is sulfonamide, amide, phosphonic acid, heterocycle, sulfonic a...
|
|
WO/1999/031057A1 |
Novel amines of formulas (1D) and (1E), or a pharmaceutically acceptable salt thereof, wherein: n is an integer of from 0 to 2; R is sulfonamide, amide, phosphonic acid, heterocycle, sulfonic acid, or hydroxamic acid; and X is -O-, -S-, ...
|
|
WO/1999/031078A1 |
The invention provides novel azulene derivatives of general formula (I) wherein R¿1? to R¿6? have the significance given in the description, as well as their tautomers, enantiomers, diastereomers, racemates and physiologically compatib...
|
|
WO/1999/028289A1 |
According to the inventive method for producing organic hydroxylamines, at least one organic nitro compound is partially hydrogenated in the presence of an organic base or ammonia, a trivalent phosphor compound and a hydrogenation cataly...
|
|
WO/1999/019323A1 |
The present invention discloses compounds of general formula (1) wherein, R?11¿ represents a 5- or 6-membered monocyclic heteroaryl group containing at least one nitrogen, or a 5- or 6-membered monocyclic heteroaryl group containing at ...
|
|
WO/1999/012911A1 |
The invention relates to a method for producing N-acylated (hetero)aromatic hydroxylamine derivatives of formula (I), wherein the substituents, the ring atom and the index have the meanings given in the Description, by hydrogenating a (h...
|
|
WO/1999/009234A2 |
In one embodiment, the present invention relates to a method of making a catalytic film comprising: applying an electric current to an electrochemical cell comprising an anode, a cathode and a solution comprising a film forming compound ...
|
